- Business
- Form
Formosa Plastics Corporation (1301.TW), founded in 1954 and headquartered in Kaohsiung, Taiwan, manufactures and sells plastic raw materials, chemical fibers, and petrochemical products primarily through its five main segments: Plastics, Polyolefins, Polypropylene, Tairylan, and Chemical. The company produces polyvinyl chloride (PVC) resins, high-density polyethylene (HDPE), linear low-density polyethylene (LLDPE), ethylene vinyl acetate (EVA) copolymer resins, polyethylene wax, polypropylene, polyoxymethylene (POM), masterbatch products, tairylan acrylic fiber, acrylic acid and esters, carbon fiber, caustic soda, PVC modifiers, and calcium carbonate. It operates manufacturing facilities in Taiwan, Mainland China, the United States—including subsidiaries in Texas, Louisiana, Delaware, and New Jersey—and internationally, serving markets in Asia and beyond as the core entity of the Formosa Plastics Group.
Recent strategic developments include a capital increase of NT$448 million for its 50%-owned venture Formosa Daikin in August 2025 to expand production of high-purity hydrofluoric acid for Taiwan's semiconductor industry, enhancing local supply amid rising demand from advanced chip manufacturers. Formosa Biomedical Technology Corp., part of the Formosa Plastics Group, signed a strategic partnership with Japan's Rohto Pharmaceutical in July 2025 for regenerative medicine CDMO services, clinical trials, and market entry in Taiwan and Japan, leveraging facilities set for GMP certification by 2026. In the U.S., expansions continue at Point Comfort, Texas, with new polyethylene, polypropylene, and olefins units operational since 2019-2021, alongside a PVC resin expansion in Baton Rouge, Louisiana, adding 300 million pounds of capacity by late 2021.